IL-12 TAVO
Intratumoral
Cancer Immunotherapy

Learn More About TAVOTM

Presentations

Piper Jaffray Conference Webcast

Corporate Presentation

KEYNOTE-695 Preliminary Data

Melanoma Bridge Presentation

 SABCS Posters

Technology Overview

TAVO Demonstration

KEYNOTE-695 SITC Poster

Clinical trials of today may power
the medical advances of tomorrow.

Learn more about our current clinical trials:

Advanced Melanoma     Triple Negative Breast Cancer

Spotlight 

Nature Gene Therapy: Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy

Immuno-Oncology News: TAVO reverses resistance to PD-1 inhibitors in metastatic melanoma, phase 2b trial suggests

Health Professionals Radio: President and CEO Dan O’Connor discusses late-stage studies in melanoma and TNBC.

News & Events

Dec 12, 2018
OncoSec Reports Updated Tumor Responses in KEYNOTE-695 Study of TAVO™ + KEYTRUDA® in Refractory Metastatic Melanoma
Dec 11, 2018
OncoSec Presents New Data Showing A Single Cycle Of Monotherapy TAVO™ Can Generate Productive Immune Responses In Triple Negative Breast Cancers (TNBC)
Dec 10, 2018
OncoSec Receives $7 Million Investment From Alpha Holdings At $1.50 Per Share
Nov 29, 2018
OncoSec Presents New Data During Oral Presentation At Melanoma Bridge Demonstrating Intratumoral Monotherapy TAVO™ Induces Abscopal Responses In Metastatic Melanoma Patients

Tavokinogene Telseplasmid “TAVO”

Taking the fight directly to the tumor

Through the intratumoral administration of IL-12, our lead product candidate, TAVO, may stimulate a safe but powerful systemic immune response leading to an innovative and potentially transformative therapy option for the treatment of cancer.

Learn More

Arming the Immune System to Fight Cancer

Clinical Pipeline

Pipeline
Our core technology platform continues to advance through clinical trials for various cancers.

Learn More

Technology

Technology
The Intratumoral IL-12 platform is designed to boost the immune system to recognize and attack tumors.

Learn More

Collaborators

Collaborators
OncoSec continues to establish relationships with industry leaders to further advance our research.

Learn More

IN THE CLINIC

Watch the Video

EXPLORE OUR TECHNOLOGY

Watch the Video

GUIDED BY SCIENCE

Visit the Site